Skip to main content

4 Result(s)

within E. Comploj Remove this filter Oncology Remove this filter

and

  1. Article

    Correction to: The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence

    In multivariate analysis, GS of the regular prostatectomy specimen was the only statistically significant parameter for pT2R1 prostate cancer.

    A. Karl, A. Buchner, C. Tympner, T. Kirchner, U. Ganswindt… in World Journal of Urology (2020)

    Download PDF (453 KB) View Article

  2. No Access

    Article

    The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence

    To predict biochemical recurrence respecting the natural course of pT2 prostate cancer with positive surgical margin (R1) and no adjuvant/neoadjuvant therapy.

    A. Karl, A. Buchner, C. Tympner, T. Kirchner, U. Ganswindt… in World Journal of Urology (2015)

  3. Article

    Open Access

    Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder

    The European Organization for Research and Treatment of Cancer (EORTC) risk tables and the Spanish Urological Club for Oncological Treatment (CUETO) scoring model are the two best-established predictive tools ...

    E Xylinas, M Kent, L Kluth, A Pycha, E Comploj, R S Svatek… in British Journal of Cancer (2013)

    Download PDF (486 KB) View Article

  4. No Access

    Article

    Positive urine cytology and carcinoma in situ prior to second transurethral resection of the bladder correlate with positive second resection histology and the need for subsequent cystectomy

    A second transurethral resection of the bladder (TURB) is recommended for high-grade bladder cancer (BC) yet yields negative results in over half of the cases. Aim of this study was to identify prognostic indi...

    M. Lodde, R. Mayr, T. Martini, E. Comploj, S. Palermo… in World Journal of Urology (2012)